CARDIOSCAPE

A survey of the European cardiovascular research landscape and recommendations for future research strategy

Coordinatore	SOCIETE EUROPEENNE DE CARDIOLOGIE    more  Organization address address: ROUTE DES COLLES 2035 city: BIOT SOPHIA ANTIPOLIS postcode: 6903 contact info Titolo: Ms. Nome: Sophie Cognome: O'kelly Email: send email Telefono: 33492947600 Fax: 33492947601
Nazionalità Coordinatore	France [FR]
Sito del progetto	http://www.cardioscape.eu/
Totale costo	546˙164 €
EC contributo	487˙365 €
Programma	FP7-HEALTH Specific Programme "Cooperation": Health
Code Call	FP7-HEALTH-2012-INNOVATION-1
Funding Scheme	CSA-SA
Anno di inizio	2012
Periodo (anno-mese-giorno)	2012-11-01   -   2014-09-30

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	SOCIETE EUROPEENNE DE CARDIOLOGIE  Organization address address: ROUTE DES COLLES 2035 city: BIOT SOPHIA ANTIPOLIS postcode: 6903 contact info Titolo: Ms. Nome: Sophie Cognome: O'kelly Email: send email Telefono: 33492947600 Fax: 33492947601	FR (BIOT SOPHIA ANTIPOLIS)	coordinator	395˙452.00
2	PNO CONSULTANTS LIMITED  Organization address address: EARL ROAD 1 THE COURTYARD city: CHEADLE HULME postcode: SK8 6GN contact info Titolo: Mr. Nome: James Roy Cognome: Craven Email: send email Telefono: +44 161 488 3488 Fax: +44 161 488 3489	UK (CHEADLE HULME)	participant	91˙913.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'CARDIOSCAPE will aim to outline the current CVD research and innovation landscape across Europe towards establishing the extent of duplication across national research programmes and the existence of gaps that reduce opportunities for innovation.

It will build on and develop an existing comprehensive partner network, seeking to include actors covering the full innovation cycle, to help identify the most important research needs and approaches that will support more efficient valorisation of project results and better foster the transmission of new scientific findings into clinical practice.

Project objectives include:

• Survey research activities and funding for CV research, both public and private, at national and European level • Create CV research and funding database based on the survey results. • Summarise existing research and funding landscape for current state-of-the-art CV research • Assess and identify gaps, strengths and weaknesses and opportunities in European CV research by expert analysis • Develop and draft a final report to outline proposed recommendations and strategy for CV research in Europe. This report could serve as the basis for later post project development of more detailed research roadmaps, supporting the EC drive towards the Horizon 2020 CSF. • Disseminate effectively to the CV research community, the various stakeholders and the wider public the project results, relating to both the existing mapped research and funding landscape and the future recommendations for a more effective coordinated research approach.

The development of recommendations for final report will be contingent on a wide ranging consultation not just within ESC but also externally, including actors and stakeholders from the pharmaceutical and medical device industries, SMEs, universities and medical research organisations, policy makers and hospitals and care organisations.'

Introduzione (Teaser)

Researchers have examined the existing cardiovascular disease (CVD) research and innovation landscape across Europe. Their goal was to determine to what extent there was duplication across national research programmes and the gaps hindering innovation.